Introduction
hyperplasia [9] . Accordingly, we recommend the routine evaluation High turnover bone disease due to excess parathyroid hormone (PTH ) is one of the central features of of the size and the blood supply to parathyroid glands by ultrasonography before starting calcitriol pulse bone abnormality in chronic dialysis patients [1] . Management of this type of uraemic bone disease has therapy ( Figure 1 ). If there is no evidence of nodular hyperplasia, PTH secretion can be usually controlled been aimed at the correction of the stimuli of PTH secretion. Thus, phosphate binders, in addition to diet-by calcitriol pulse therapy without difficulty. By contrast, if one or more enlarged glands suggestive of ary phosphorus restriction and oral active vitamin D sterols, have been used in most of these patients [2] . nodular hyperplasia are found, it is unlikely that PTH secretion can be controlled in the long-term even by Among routinely available therapeutic modalities, calcitriol pulse therapy is considered to be the most potent calcitriol pulse therapy.
How have such patients been treated in the past? medical therapy [3] . Nevertheless, some patients are even refractory to this therapy. Such patients usually They may have been treated by calcitriol pulse therapy.
Often this failed to cause significant suppression of have one or more enlarged parathyroid glands [4] , and could be managed only by surgical parathyroidectomy PTH, but often caused hypercalcaemia so that at the end of the day one was forced to consider surgical until recently [5] . In this brief review, we would like to present a new approach to such patients which is parathyroidectomy. We propose that one should not try to treat such patients using calcitriol pulse therapy currently becoming popular in Japan.
for more than 3 months if there is no evidence of significant PTH suppression, because we are concerned
Parathyroid hyperplasia: pathophysiology and
about the high risk of ectopic calcification. In such clinical significance patients, we propose that one should even skip calcitriol pulse therapy ( Figure 1 ). Recent researches with surgically removed parathyroid New vitamin D analogues [10] , calcimicetics [11] , glands have elucidated that parathyroid hyperplasia in or their combinations may be effective in such patients. uraemic patients develops initially from diffuse hyper-Whether this approach proves to be successful will plasia [6 ] . Some cells with more severe reduction of have to be examined in near future. Until such evidence calcitriol receptor [7] and calcium-sensing receptor is available, we have adopted and developed a new within diffuse hyperplasia then begin to proliferate strategy for such patients, i.e. percutaneous ethanol more vigorously and monoclonally [8] , and progress injection therapy (PEIT ). to nodule formation, finally to nodular hyperplasia.
PEIT was introduced by Italian pioneers in early As can be seen, patients with nodular hyperplasia are 1980s [12] , initially as an alternative to surgical parausually more resistant to medical therapy including thyroidectomy. We have further developed this techcalcitriol pulse therapy than those only with diffuse nique as an adjunct to medical therapy instead. To this hyperplasia [6 ] .
end we established the technique of 'selective PEIT of Thus, it is critical to distinguish between diffuse and parathyroid'. This involves selective destruction of nodular hyperplasia in the selection of the optimal enlarged parathyroid glands with presumed nodular therapeutic modalities. One useful index is the size of hyperplasia using ethanol injection. The remaining the gland. Careful clinical observations and patholo-glands with presumed diffuse hyperplasia are then gical analyses suggest that most of the glands larger managed by medical therapy. Today with sufficient than 0.5 cm3, or 1 cm in diameter, exhibit usually theoretical background, operator experience and nodular hyperplasia [4, 5] . In addition, blood supply technological expertise, we can apply this technique to the gland evaluated by colour Doppler imaging may efficiently and safely.
According to the recent survey by the Japanese and based on pathophysiological consideration, we concentration (<10.5 mg/dl ); (ii) evidence of high proposed a 'tentative guideline of selective PEIT of turnover bone disease by imaging study or by serum parathyroid'. This was done to establish the indications markers of bone turnover, or ideally by bone biopsy; for this therapy, to optimize its efficacy and to minimize (iii) confirmation of at least one critically enlarged the risk of ethanol injection. Because the tentative parathyroid gland by ultrasonography, within the guideline was published in Japanese [13], we give a reach of the PEIT needle; (iv) resistance to medical brief summary here.
therapy and (v) consent of the patient. In addition, aluminium bone should be excluded.
In such patients, all glands larger than 1 cm in Principles of selective PEIT of parathyroid in diameter or 0.5 cm3 in calculated volume, are selecturaemic patients ively destroyed by injection of 90% ethanol with 1% lidocaine under ultrasonographic control. For safety, the initial injection volume should not exceed 80% of First of all, it is mandatory for this therapy to be the calculated volume of the gland. It is also mandatory performed by a skillful operator who is an expert of to confirm that the tip of the needle is in the centre of the anatomy and imaging of the neck. An ultrasonothe gland. Ethanol should be injected slowly to avoid graphic machine with sufficiently high specifications leaks from the gland. As reported earlier, we have must be used, i.e. an electronic linear scanner or a developed a special needle for PEIT with side holes mechanical sector scanner (7.5 MHz or more) with for homogeneous distribution of ethanol and with high resolution (0.5 mm). In addition, we strongly modification of the tip for easy detection by ultrasonorecommend the routine use of colour Doppler imaging graphy [15] . in order to confirm destruction of parathyroid tissue Since we are able to detect residual blood supply to guarantee efficacy and safety of PEIT [14] with high accuracy, additional ethanol injection can (Figure 2 ). Colour Doppler imaging is also very helpful be performed with a minimal amount of ethanol. The to localize the exact site of additional ethanol injections interval between initial and subsequent additional ethand to recognize recurrence of local cell growth.
anol injections varies depending upon the protocol The criteria for selective PEIT include: (i) high PTH [15] [16] [17] . Serum PTH and residual blood supply should concentration (intact PTH >400 pg/ml ) at physiological calcium concentration corrected for albumin be checked no later than 1 month after the initial CA : Common Carotid Artery SCM: Sternocleidomastoid Muscle PT : Parathyroid T : Thyroid ethanol injection. With such care and technical modi-be taken in performing PEIT for patients of recurrent hyperparathyroidism with a previous history of fications, the risk of recurrent nerve palsy has become minimal [17] . Nevertheless, compensated unilateral subtotal parathyroidectomy [17] .
Another controversial issue that has to be addressed recurrent nerve palsy should be ruled out before PEIT.
Careful follow-up of parathyroid function is more is the relative indication for PEIT and surgical parathyroidectomy. Of course, high-risk patients for surgical important than the ethanol injection itself. The patients are usually treated using calcitriol pulse therapy dir-parathyroidectomy are good candidates for PEIT.
Although the technique permits to destroy as many ectly after initial PEIT. This is followed by oral treatment with active vitamin D once the PTH concen-glands as we like, long-term follow-up suggested that patients with more than three critically enlarged glands tration has been suppressed. In addition to the monthly check of serum PTH levels, it is useful to survey for should be managed by surgical parathyroidectomy. the recurrence of cell growth by colour flow mapping at several months' interval or when PTH concentration begins to increase again. Recurrence of cell growth Future Directions within the destroyed gland can be treated with injection of a minimum amount of ethanol whenever it is As can be seen, selective PEIT has become a new recognized. Nevertheless, the criteria for initial PEIT option for the treatment of patients with severe second-(see above) should be applied when undestroyed glands ary hyperparathyroidism resistant to medical therapy. become enlarged. If the PTH concentration does not We plan to report the final version of the guidelines decrease despite complete destruction of the target next year after sufficient verification and discussion. glands, the presence of undetected or ectopic gland(s) Moreover, this route permits selective delivery of drugs should be excluded using scintigraphy, CT or MRI into the parathyroid gland. As already reported by [14] ( Figure 1 ). This is the only pitfall of PEIT because several groups including ours [19] , direct injection of we do not routinely check ectopic glands prior to calcitriol solution has been tested in uraemic patients PEIT, in contrast to the preoperative evaluation before and gene transfer to enlarged parathyroid glands has surgical parathyroidectomy.
been tried in rats. Such techniques of intervention may On the other hand, permanent hypoparathyroidism in the future provide the option of pharmacological is an important side effect of surgical parathyroidecparathyroidectomy. tomy which may be a cause of adynamic bone disease as recently recognized [18] . As we have reported recently, selective PEIT in combination with appro-Acknowledgements. We would like to express our thanks to members priate medical therapy causes a minimal risk of relative of 'Japanese Working Group on PEIT of Parathyroid' for discussion on the 'tentative guideline of selective PEIT of parathyroid'. hypoparathyroidism at best. By contrast, care should
